Inhaled nitric oxide in acute respiratory failure.

Inhaled nitric oxide in acute respiratory failure in adults.

We have assessed the acute effects of inhaled nitric oxide 8, 32 and 128 volumes per million (vpm) on pulmonary haemodynamics and arterial oxygenation in patients with severe acute respiratory failure. Fourteen patients requiring artificial ventilation with mean pulmonary artery pressures greater than 30 mm Hg were given inhaled nitric oxide; haemodynamic values and blood-gas tensions were meas...

Serum nitrogen oxides during nitric oxide inhalation.

A patient with acute respiratory failure secondary to leptospirosis was treated with 40 and 90 volumes per million inhaled nitric oxide. His serum nitrogen oxide concentration (nitrates and nitrites combined) increased 13-fold. The mechanisms for the formation and elimination of nitrates are discussed.

Inhaled nitric oxide as salvage therapy in massive pulmonary embolism: a case series.

Inhaled nitric oxide (INO) has been shown to preferentially lower resistance in the pulmonary vasculature. The relative selectiveness of INO in accomplishing this effect makes it an attractive drug to administer as salvage therapy in patients with acute right ventricular failure secondary to pulmonary embolism. We describe 4 cases in which INO was used as a temporizing agent to decrease right ...

(54) Methods of Reducing the Risk of Occurrence of Pulmonary Edema in Term or Near-term Neonates in Need of Treatment with Inhaled Nitric Oxide

The American Illustrated Medical Dictionary (Dorland, 1914, 7th Ed, p. 113).* Beghetti et al. (Journal of Pediatrics, 1997, p. 844).* Macrae et al. (Intensive Care Med 2004, 30, pp. 372-380).* AtZ et al. (Seminars in Perinatology 1997, 21(5), pp. 441-455).* Kinsella et al. (The Lancet 1999, 354, pp. 1061-1065).* The NIH (Critical Care Therapy and Respiratory Care Section; Nitric Oxide Therapy, ...

Neonatal ventilation with INhaled Nitric Oxide versus Ventilatory support withOut inhaled nitric oxide for severe respiratory failure: a multicentre randomized controlled trial

American Academy of Pediatrics. Committee on Fetus and Newborn. Use of inhaled nitric oxide.

Approval of inhaled nitric oxide by the US Food and Drug Administration for hypoxic respiratory failure of the term and near-term newborn provides an important new therapy for this serious condition. This statement addresses the conditions under which inhaled nitric oxide should be administered to the neonate with hypoxic respiratory failure.